Clinical trial

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation…

NCT00402714 · Yale University, Other · Completed

Key facts

NCT number NCT00402714
Title A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Official title A Randomized Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation Versus Pentostatin and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Lead sponsor Yale University, Other
Collaborators Hospira, now a wholly owned subsidiary of Pfizer Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Hematologic Malignancies
Intervention type Drug, Procedure, Radiation
Interventions extracorporeal photopheresis, Pentostatin, Total Body Irradiation
Enrollment 14
Start date Jul 1, 2006
Primary completion Jul 1, 2009
Completion Aug 1, 2009
First posted Nov 22, 2006
Last update posted Jan 18, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies